Charles River Laboratories International (CRL) Contributed to Madison Small Cap Fund’s Healthcare Outperformance

Madison Investments, an investment advisor, released its “Madison Small Cap Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here. The Fund outperformed its small-cap benchmarks during the third quarter of 2026, despite a challenging environment for quality-focused investors as speculative AI-related stocks retreated, inflation remained persistent, and rising bond yields pressured rate-sensitive businesses. The Fund’s Class R6 shares declined 5.80%, compared with...